Replimune Group, Inc.
Ticker: REPL
| Insider | Title |
|---|---|
| Andrew Schwendenman | Chief Accounting Officer |
| Christopher Sarchi | Chief Commercial Officer |
| Christy J. Oliger | Director |
| Colin Love | Chief Operating Officer |
| Dieter Weinand | Director |
| Emily Luisa Hill | Chief Financial Officer |
| Fund Iv G.p. Manager, Ltd. Omega | 10% or greater ownership |
| Fund Iv Gp, L.p. Omega | 10% or greater ownership |
| Fund Iv, L.p. Omega | 10% or greater ownership |
| Hugo Alexander Slootweg | Director |
| Hyam Levitsky | Director |
| Jason P Rhodes | Director |
| Jean M. Franchi | Chief Financial Officer |
| Joseph P Slattery | Director |
| Kapil Dhingra | Director |
| Konstantinos Xynos | Chief Medical Officer |
| Madhavan Balachandran | Director |
| Otello Stampacchia | 10% or greater ownership |
| Pamela Esposito | Chief Business Officer |
| Paolo Pucci | Director |
| Philip Astley-sparke | Executive Chairman, Director |
| Robert Coffin | Director |
| Sushil Patel | Chief Executive Officer, Director |
| Tanya Lewis | Chief Dev. Op. Officer |
| Veleka Peeples-dyer | Director |